A detailed history of Financial & Tax Architects, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial & Tax Architects, LLC holds 35,420 shares of ABBV stock, worth $6.31 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
35,420
Previous 37,551 5.67%
Holding current value
$6.31 Million
Previous $6.44 Billion 8.6%
% of portfolio
1.8%
Previous 1.73%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $349,143 - $424,772
-2,131 Reduced 5.67%
35,420 $6.99 Billion
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $332,179 - $387,910
2,146 Added 6.06%
37,551 $6.44 Billion
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $277,447 - $316,125
-1,736 Reduced 4.67%
35,405 $6.45 Billion
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $23,116 - $26,034
-168 Reduced 0.45%
37,141 $5.76 Billion
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $282,676 - $327,239
2,116 Added 6.01%
37,309 $5.56 Billion
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $375,665 - $467,491
2,835 Added 8.76%
35,193 $4.74 Billion
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $249,018 - $286,781
1,722 Added 5.62%
32,358 $5.16 Billion
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $4.24 Million - $5.08 Million
30,636 New
30,636 $4.58 Billion
Q3 2022

Aug 25, 2023

SELL
$134.21 - $153.93 $226,412 - $259,679
-1,687 Reduced 4.79%
33,506 $4.5 Billion
Q2 2022

Aug 25, 2023

BUY
$137.62 - $174.96 $352,857 - $448,597
2,564 Added 8.79%
31,720 $4.86 Billion
Q1 2022

Aug 25, 2023

SELL
$131.98 - $163.75 $796,763 - $988,558
-6,037 Reduced 17.15%
29,156 $4.73 Billion
Q4 2021

Aug 25, 2023

BUY
$107.43 - $135.93 $190,151 - $240,596
1,770 Added 5.77%
32,449 $4.39 Billion
Q3 2021

Aug 25, 2023

BUY
$106.4 - $120.78 $177,794 - $201,823
1,671 Added 5.76%
30,679 $3.31 Billion
Q2 2021

Aug 25, 2023

BUY
$105.21 - $117.21 $229,673 - $255,869
2,183 Added 8.14%
29,008 $3.27 Billion
Q1 2021

Aug 25, 2023

SELL
$102.3 - $112.62 $856,046 - $942,404
-8,368 Reduced 23.78%
26,825 $2.9 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial & Tax Architects, LLC Portfolio

Follow Financial & Tax Architects, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial & Tax Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial & Tax Architects, LLC with notifications on news.